TRML Stock Discussion
Tourmaline Bio, Inc. Description
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Industry: Biotechnology
Keywords: Biotechnology Medication Thyroid Eye Disease Atherosclerosis Immune Diseases
Recent Comments
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
From the Blog
Featured Articles